STOK | Stoke Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Bedford, Massachusetts, United States Trade prices Volume: Market Cap: 539.64M Prev closed: Open: 24.62 High: 24.95 Low: 23.86 52 week low: 16.62 52 week high: 50.33 Dividends: No Dividends Next ER: August 16, 2022 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast November 16, 2022 August 8, 2022 -0.63 / -0.68763.23M / 2.64MBeat! May 10, 2022 -0.66 / 0.36193M / 50MMarch 10, 2022 -0.66 / -0.6234- / -November 17, 2021 - / -0.4902- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 19.99 21.38 22.11
19.72
129.59K -6.81% Aug 15, 2022 21.45 21.38 22.46
21.05
136.90K -0.69% Aug 12, 2022 21.60 20.98 22.34
20.81
129.70K 3.95% Aug 11, 2022 20.78 22.39 22.39
20.48
164.75K -7.77% Aug 10, 2022 22.53 21.89 22.87
21.67
319.14K 1.90% Aug 9, 2022 22.11 21.92 22.46
20.87
353.96K 4.49% Aug 8, 2022 21.16 17.00 22.17
17.00
392.89K 26.03% Aug 5, 2022 16.79 15.97 16.92
15.80
111.06K 2.69% Aug 4, 2022 16.35 15.63 16.75
15.51
164.82K 5.69% Aug 3, 2022 15.47 15.41 16.61
15.41
123.48K 2.45% view more
NASDAQ - Nasdaq Stock Market
News
Acadia, Stoke Team Up In $900M+ Deal On RNA Therapies For CNS Disorders finance.yahoo.com Mar 24, 2022 8:11 am Stoke Therapeutics GAAP EPS of -$0.66 misses by $0.04 seekingalpha.com Mar 10, 2022 8:48 pm
Stoke Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates finance.yahoo.com Mar 10, 2022 7:00 am
Wall Street Analysts Believe Stoke Therapeutics, Inc. (STOK) Could Rally 184%: Here's is How to Trade finance.yahoo.com Feb 28, 2022 10:00 am
Wall Street Analysts See a 192% Upside in Stoke Therapeutics, Inc. (STOK): Can the Stock Really Move This High? finance.yahoo.com Feb 10, 2022 10:00 am Stoke Therapeutics initiated Buy at Jefferies on potential of RNA platform seekingalpha.com Feb 1, 2022 2:08 am
Acadia (ACAD) Partners With Stoke for CNS Disorder Therapies finance.yahoo.com Jan 11, 2022 11:56 am
Stoke Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference finance.yahoo.com Jan 4, 2022 7:30 am Stoke Therapeutics shares data from Phase 1/2a trial for STK-001 in Dravet syndrome seekingalpha.com Dec 3, 2021 11:29 pm
Moore Kuehn, PLLC Encourages Investors of Stoke Therapeutics, Inc. to Contact Law Firm finance.yahoo.com Nov 30, 2021 9:16 am
Stoke Therapeutics Announces Presentations Related to the Companys Work to Advance STK-001, the First Potential New Medicine to Target the Underlying Cause of Dravet Syndrome at the American Epilepsy Society (AES) 2020 Annual Meeting finance.yahoo.com Nov 22, 2021 9:57 am
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway finance.yahoo.com Nov 22, 2021 8:17 am
Mersana Therapeutics to Present at Upcoming Investor Conferences finance.yahoo.com Nov 22, 2021 8:00 am Stoke Therapeutics up 14% following J.P. Morgan upgrade to overweight seekingalpha.com Nov 23, 2021 2:10 am
Mersana Therapeutics Receives FDA Fast Track Designation for XMT-1536 for the Treatment of Patients with Platinum-resistant Ovarian Cancer finance.yahoo.com Nov 22, 2021 8:00 am
Stoke Therapeutics to Present at 29th Annual Credit Suisse Virtual Healthcare Conference finance.yahoo.com Nov 22, 2021 7:30 am
Mersana Therapeutics to Host Webinar Highlighting Immunosynthen STING-Agonist ADC Platform and Pipeline finance.yahoo.com Nov 22, 2021 7:30 am
Stoke Therapeutics Announces Positive Interim Safety, PK and CSF Exposure Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome finance.yahoo.com Nov 22, 2021 6:59 am
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update finance.yahoo.com Nov 22, 2021 6:00 am
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update finance.yahoo.com Nov 22, 2021 6:00 am This company doesn't provide a dividend.
Talk about Stoke Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?